CITATIONS


JOP. J Pancreas (Online) 2003; 4(1):75-82.

Antiproteasic Agents in the Prevention of Post-ERCP Pancreatitis: Rationale for Use and Clinical Results

Cavallini G, Frulloni L

Department of Surgical and Gastroenterological Sciences, University of Verona. Verona, Italy


Cited by:

6

Kitagawa M, Hayakawa T. Antiproteases in the Treatment of Acute Pancreatitis. JOP. J Pancreas (Online) 2007; 8(4 Suppl):518-525. [More details]

5

Kitagawa M, Hayakawa T. Antiproteases and the Pancreas: Basic and Clinical Update. Conclusion Remarks. JOP. J Pancreas (Online) 2007; 8(4 Suppl):538-544. [More details]

4

Lowe ME. Pancreatitis in childhood. Curr Gastroenterol Rep 2004; 6(3):240-6. [More details]

3

Cavallini G, Frulloni, L. La pancreatite acuta: fisiopatologia e implicazioni terapeutiche. JournalOnlineit [More details]

2

Seta T, Noguchi Y, Shimada T, Shikata S, Fukui T. Treatment of acute pancreatitis with protease inhibitors: a meta-analysis. Eur J Gastroenterol Hepatol 2004; 16(12):1287-93. [More details]

1

Freeman ML. Prevention of post-ERCP pancreatitis: Pharmacologic solution or patient selection and pancreatic stents?. Gastroenterology 2003; 124(7):1977-80. [More details]